{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T01:11:31Z","timestamp":1743383491745},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12885-015-1805-9","type":"journal-article","created":{"date-parts":[[2015,10,20]],"date-time":"2015-10-20T20:31:53Z","timestamp":1445373113000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of liver cirrhosis due to chronic hepatitis C viral infection on the outcome of ovarian cancer: a prospective study"],"prefix":"10.1186","volume":"15","author":[{"given":"Basel","family":"Refky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sherif","family":"Kotb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamer","family":"Fady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Marwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doaa","family":"Abd El-Khalek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed","family":"Elnahas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed T.","family":"Hafez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduard","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amr A.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,21]]},"reference":[{"issue":"2","key":"1805_CR1","first-page":"87","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA: Cancer J Clinicians. 2015;65(2):87\u2013108.","journal-title":"CA: Cancer J Clinicians"},{"key":"1805_CR2","volume-title":"S3-leitlinie diagnostik, therapie und nachsorge maligner ovarialtumoren","author":"AGO-Leitlinienkommission","year":"2013","unstructured":"AGO-Leitlinienkommission. S3-leitlinie diagnostik, therapie und nachsorge maligner ovarialtumoren. 2013."},{"key":"1805_CR3","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","volume":"363","author":"I Vergote","year":"2010","unstructured":"Vergote I, Trop\u00e9 C, Amant F, Kristensen G, Ehlen T, Johnson N, et al. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. N Engl J Med. 2010;363:943\u201353.","journal-title":"N Engl J Med"},{"issue":"1","key":"1805_CR4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ygyno.2004.12.026","volume":"97","author":"HA Maas","year":"2005","unstructured":"Maas HA, Kruitwagen RF, Lemmens VE, Goey SH, Janssen-Heijnen ML. The influence of age and co-morbidity on treatment and prognosis of ovarian cancer: a population-based study. Gynecol Oncol. 2005;97(1):104\u20139.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"1805_CR5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ygyno.2012.07.001","volume":"127","author":"TL Jorgensen","year":"2012","unstructured":"Jorgensen TL, Teiblum S, Paludan M, Poulsen LO, Jorgensen AY, Bruun KH, et al. Significance of age and comorbidity on treatment modality, treatment adherence, and prognosis in elderly ovarian cancer patients. Gynecol Oncol. 2012;127(2):367\u201374.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"1805_CR6","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ygyno.2010.12.329","volume":"121","author":"A Bakhru","year":"2011","unstructured":"Bakhru A, Buckanovich RJ, Griggs JJ. The impact of diabetes on survival in women with ovarian cancer. Gynecol Oncol. 2011;121(1):106\u201311.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"1805_CR7","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ygyno.2013.02.014","volume":"129","author":"VM Chia","year":"2013","unstructured":"Chia VM, O\u2019Malley CD, Danese MD, Lindquist KJ, Gleeson ML, Kelsh MA, et al. Prevalence and incidence of comorbidities in elderly women with ovarian cancer. Gynecol Oncol. 2013;129(2):346\u201352.","journal-title":"Gynecol Oncol"},{"issue":"33","key":"1805_CR8","doi-asserted-by":"crossref","first-page":"14757","DOI":"10.1073\/pnas.1008877107","volume":"107","author":"FD Miller","year":"2010","unstructured":"Miller FD, Abu-Raddad LJ. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proc Natl Acad Sci U S A. 2010;107(33):14757\u201362.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1805_CR9","volume-title":"Egypt demographic and health survey 2008","author":"F El-Zanaty","year":"2009","unstructured":"El-Zanaty F, Way A. Egypt demographic and health survey 2008. Cairo: Egyptian Ministry of Health; 2009."},{"key":"1805_CR10","volume-title":"World Health Statistics 2011","author":"WHO","year":"2011","unstructured":"WHO. World Health Statistics 2011. Geneva: WHO; 2011."},{"key":"1805_CR11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1186\/1471-2334-13-288","volume":"13","author":"YA Mohamoud","year":"2013","unstructured":"Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infect Dis. 2013;13:288.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"1805_CR12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","volume":"17","author":"D Lavanchy","year":"2011","unstructured":"Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect. 2011;17(2):107\u201315.","journal-title":"Clin Microbiol Infect"},{"issue":"16","key":"1805_CR13","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199904223401602","volume":"340","author":"E Kenny-Walsh","year":"1999","unstructured":"Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med. 1999;340(16):1228\u201333.","journal-title":"N Engl J Med"},{"issue":"1","key":"1805_CR14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","volume":"44","author":"G D\u2019Amico","year":"2006","unstructured":"D\u2019Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44(1):217\u201331.","journal-title":"J Hepatol"},{"key":"1805_CR15","first-page":"192","volume":"121","author":"LS Friedman","year":"2010","unstructured":"Friedman LS. Surgery in the patient with liver disease. Trans Am Clin Climatol Assoc. 2010;121:192\u2013204. discussion 205.","journal-title":"Trans Am Clin Climatol Assoc"},{"issue":"8","key":"1805_CR16","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1139\/y87-276","volume":"65","author":"S Gelman","year":"1987","unstructured":"Gelman S. General anesthesia and hepatic circulation. Can J Physiol Pharmacol. 1987;65(8):1762\u201379.","journal-title":"Can J Physiol Pharmacol"},{"issue":"8","key":"1805_CR17","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RN Pugh","year":"1973","unstructured":"Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60(8):646\u20139.","journal-title":"Br J Surg"},{"issue":"5","key":"1805_CR18","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.amjsurg.2004.07.034","volume":"188","author":"N Farnsworth","year":"2004","unstructured":"Farnsworth N, Fagan SP, Berger DH, Awad SS. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients. Am J Surg. 2004;188(5):580\u20133.","journal-title":"Am J Surg"},{"issue":"6","key":"1805_CR19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649\u201355.","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"1805_CR20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejrad.2006.11.003","volume":"61","author":"G Brancatelli","year":"2007","unstructured":"Brancatelli G, Federle MP, Ambrosini R, Lagalla R, Carriero A, Midiri M, et al. Cirrhosis: CT and MR imaging evaluation. Eur J Radiol. 2007;61(1):57\u201369.","journal-title":"Eur J Radiol"},{"issue":"3","key":"1805_CR21","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejrad.2004.08.001","volume":"54","author":"OB Saygili","year":"2005","unstructured":"Saygili OB, Tarhan NC, Yildirim T, Serin E, Ozer B, Agildere AM. Value of computed tomography and magnetic resonance imaging for assessing severity of liver cirrhosis secondary to viral hepatitis. Eur J Radiol. 2005;54(3):400\u20137.","journal-title":"Eur J Radiol"},{"issue":"6\u20137","key":"1805_CR22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.gcb.2009.03.012","volume":"33","author":"R Douard","year":"2009","unstructured":"Douard R, Lentschener C, Ozier Y, Dousset B. Operative risks of digestive surgery in cirrhotic patients. Gastroenterol Clin Biol. 2009;33(6\u20137):555\u201364.","journal-title":"Gastroenterol Clin Biol"},{"issue":"6","key":"1805_CR23","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/jso.23856","volume":"111","author":"JM Regimbeau","year":"2015","unstructured":"Regimbeau JM, Rebibo L, Dokmak S, Boher JM, Sauvanet A, Chopin-Laly X, et al. The short- and long-term outcomes of pancreaticoduodenectomy for cancer in Child A patients are acceptable: a patient-control study from the Surgical French Association report for pancreatic surgery. Eur J Surg Oncol. 2015;111(6):776\u201383.","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"1805_CR24","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/ijc.22532","volume":"120","author":"LV Poll-Franse van de","year":"2007","unstructured":"van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer. 2007;120(9):1986\u201392.","journal-title":"Int J Cancer"},{"issue":"5","key":"1805_CR25","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/IGC.0b013e31824b403d","volume":"22","author":"JS Ferriss","year":"2012","unstructured":"Ferriss JS, Ring K, King ER, Courtney-Brooks M, Duska LR, Taylor PT. Does significant medical comorbidity negate the benefit of up-front cytoreduction in advanced ovarian cancer? Int J Gynecol Cancer: Off J Intern Gynecological Cancer Soc. 2012;22(5):762\u20139.","journal-title":"Int J Gynecol Cancer: Off J Intern Gynecological Cancer Soc"},{"key":"1805_CR26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-2407-8-31","volume":"8","author":"MS Tetsche","year":"2008","unstructured":"Tetsche MS, Dethlefsen C, Pedersen L, Sorensen HT, Norgaard M. The impact of comorbidity and stage on ovarian cancer mortality: a nationwide Danish cohort study. BMC Cancer. 2008;8:31.","journal-title":"BMC Cancer"},{"issue":"9","key":"1805_CR27","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1089\/jwh.2012.3781","volume":"21","author":"CD O\u2019Malley","year":"2012","unstructured":"O\u2019Malley CD, Shema SJ, Cress RD, Bauer K, Kahn AR, Schymura MJ, et al. The implications of age and comorbidity on survival following epithelial ovarian cancer: summary and results from a Centers for Disease Control and Prevention study. J Womens Health (Larchmt). 2012;21(9):887\u201394.","journal-title":"J Womens Health (Larchmt)"},{"issue":"1","key":"1805_CR28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/AOG.0b013e31823d4006","volume":"119","author":"DM Chase","year":"2012","unstructured":"Chase DM, Fedewa S, Chou TS, Chen A, Ward E, Brewster WR. Disparities in the allocation of treatment in advanced ovarian cancer: are there certain patient characteristics associated with nonstandard therapy? Obstet Gynecol. 2012;119(1):68\u201377.","journal-title":"Obstet Gynecol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-015-1805-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T17:41:45Z","timestamp":1498239705000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2407\/15\/754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,21]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1805"],"URL":"https:\/\/doi.org\/10.1186\/s12885-015-1805-9","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,21]]},"article-number":"754"}}